Walter Joseph O'Donnell, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Administrative Personnel | 1 | 2022 | 186 | 0.720 |
Why?
|
| Harm Reduction | 1 | 2022 | 141 | 0.720 |
Why?
|
| Electronic Health Records | 4 | 2023 | 4863 | 0.500 |
Why?
|
| Medicine | 1 | 2022 | 944 | 0.440 |
Why?
|
| Physicians | 2 | 2024 | 4591 | 0.310 |
Why?
|
| Patient Discharge | 2 | 2017 | 3460 | 0.260 |
Why?
|
| Pneumonia, Pneumocystis | 2 | 1998 | 241 | 0.260 |
Why?
|
| Acute Lung Injury | 2 | 2018 | 377 | 0.220 |
Why?
|
| AIDS-Related Opportunistic Infections | 2 | 1998 | 663 | 0.220 |
Why?
|
| Pneumonia | 3 | 2011 | 2158 | 0.180 |
Why?
|
| Social Responsibility | 1 | 2024 | 382 | 0.180 |
Why?
|
| Hospitals, Teaching | 2 | 2011 | 1156 | 0.160 |
Why?
|
| Pneumocystis | 1 | 1998 | 55 | 0.160 |
Why?
|
| Attitude of Health Personnel | 2 | 2022 | 3928 | 0.150 |
Why?
|
| Bronchiolitis | 1 | 2004 | 492 | 0.150 |
Why?
|
| Employment | 1 | 2023 | 1107 | 0.140 |
Why?
|
| Sputum | 2 | 1998 | 513 | 0.130 |
Why?
|
| Lung Transplantation | 4 | 2018 | 1311 | 0.130 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2004 | 940 | 0.130 |
Why?
|
| Internal Medicine | 1 | 2003 | 1064 | 0.120 |
Why?
|
| Furosemide | 2 | 1994 | 174 | 0.120 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2017 | 264 | 0.120 |
Why?
|
| Physicians, Primary Care | 1 | 2022 | 622 | 0.120 |
Why?
|
| Pulmonary Alveoli | 1 | 2018 | 665 | 0.120 |
Why?
|
| Pulmonary Fibrosis | 1 | 2018 | 503 | 0.110 |
Why?
|
| Burnout, Professional | 1 | 2022 | 710 | 0.100 |
Why?
|
| Carcinoma, Small Cell | 1 | 1995 | 420 | 0.100 |
Why?
|
| Acetazolamide | 1 | 1992 | 98 | 0.100 |
Why?
|
| Commerce | 1 | 2017 | 612 | 0.100 |
Why?
|
| Pulmonary Alveolar Proteinosis | 1 | 2011 | 41 | 0.090 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2011 | 131 | 0.090 |
Why?
|
| Lung | 2 | 2011 | 10046 | 0.090 |
Why?
|
| Diuretics | 1 | 1994 | 611 | 0.090 |
Why?
|
| Uric Acid | 1 | 1996 | 809 | 0.090 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2018 | 1481 | 0.080 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2011 | 755 | 0.080 |
Why?
|
| Regeneration | 1 | 2018 | 1516 | 0.080 |
Why?
|
| Anti-Infective Agents | 1 | 1996 | 985 | 0.080 |
Why?
|
| Smoking | 2 | 2004 | 9082 | 0.080 |
Why?
|
| Internship and Residency | 2 | 2011 | 5945 | 0.070 |
Why?
|
| Efficiency, Organizational | 1 | 2011 | 695 | 0.070 |
Why?
|
| Hospitalists | 1 | 2011 | 297 | 0.070 |
Why?
|
| Humans | 29 | 2024 | 765926 | 0.070 |
Why?
|
| Asthma | 3 | 1995 | 6268 | 0.070 |
Why?
|
| Schizophrenia | 1 | 2004 | 6971 | 0.060 |
Why?
|
| Education, Medical, Continuing | 1 | 2011 | 829 | 0.060 |
Why?
|
| Cough | 2 | 2011 | 598 | 0.060 |
Why?
|
| Tomography, Emission-Computed | 1 | 2008 | 1006 | 0.060 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2012 | 996 | 0.060 |
Why?
|
| Referral and Consultation | 1 | 2017 | 3615 | 0.060 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2012 | 1176 | 0.050 |
Why?
|
| Sarcoidosis | 1 | 2008 | 533 | 0.050 |
Why?
|
| Cardiomegaly | 1 | 2004 | 590 | 0.050 |
Why?
|
| Dyspnea | 2 | 2011 | 1351 | 0.050 |
Why?
|
| Pennsylvania | 1 | 2003 | 615 | 0.050 |
Why?
|
| Administration, Inhalation | 2 | 1994 | 1154 | 0.040 |
Why?
|
| Periodicals as Topic | 1 | 2011 | 1463 | 0.040 |
Why?
|
| United States | 4 | 2024 | 72909 | 0.040 |
Why?
|
| Recurrence | 2 | 2004 | 8492 | 0.040 |
Why?
|
| Intensive Care Units | 1 | 2012 | 3799 | 0.040 |
Why?
|
| Tobacco Use Disorder | 1 | 2004 | 708 | 0.040 |
Why?
|
| Fluorescent Antibody Technique, Direct | 1 | 1998 | 65 | 0.040 |
Why?
|
| Decision Making | 1 | 2012 | 3955 | 0.040 |
Why?
|
| Communication | 1 | 2012 | 3908 | 0.040 |
Why?
|
| Lung Diseases, Obstructive | 1 | 1998 | 309 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2011 | 5339 | 0.030 |
Why?
|
| Workflow | 1 | 2022 | 859 | 0.030 |
Why?
|
| Cohort Studies | 5 | 2022 | 41680 | 0.030 |
Why?
|
| Lymphoma, Large-Cell, Immunoblastic | 1 | 1996 | 25 | 0.030 |
Why?
|
| Patient Readmission | 1 | 2011 | 3282 | 0.030 |
Why?
|
| Models, Statistical | 1 | 2011 | 5088 | 0.030 |
Why?
|
| Time | 1 | 2018 | 549 | 0.030 |
Why?
|
| Workload | 1 | 2022 | 848 | 0.030 |
Why?
|
| Medicare | 2 | 2011 | 6815 | 0.030 |
Why?
|
| Leukotriene E4 | 1 | 1995 | 75 | 0.030 |
Why?
|
| Male | 17 | 2018 | 363815 | 0.030 |
Why?
|
| Situs Inversus | 1 | 1994 | 63 | 0.030 |
Why?
|
| Female | 15 | 2018 | 396141 | 0.030 |
Why?
|
| Histamine | 1 | 1995 | 496 | 0.030 |
Why?
|
| Radiography | 1 | 2004 | 6941 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2008 | 12973 | 0.030 |
Why?
|
| Smoking Cessation | 1 | 2004 | 2084 | 0.030 |
Why?
|
| Biopsy | 1 | 2004 | 6766 | 0.030 |
Why?
|
| Hyperventilation | 1 | 1992 | 78 | 0.030 |
Why?
|
| Bronchial Provocation Tests | 1 | 1992 | 216 | 0.030 |
Why?
|
| Bronchiectasis | 1 | 1994 | 141 | 0.030 |
Why?
|
| Data Collection | 1 | 2022 | 3318 | 0.030 |
Why?
|
| Adult | 12 | 2018 | 223088 | 0.020 |
Why?
|
| Forced Expiratory Volume | 2 | 1998 | 1828 | 0.020 |
Why?
|
| Humidity | 1 | 1992 | 206 | 0.020 |
Why?
|
| Proxy | 1 | 2012 | 150 | 0.020 |
Why?
|
| Urine | 1 | 1992 | 363 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 1995 | 13446 | 0.020 |
Why?
|
| Middle Aged | 9 | 2017 | 223016 | 0.020 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2004 | 3247 | 0.020 |
Why?
|
| Bronchoscopy | 1 | 1995 | 913 | 0.020 |
Why?
|
| Macrophages, Alveolar | 1 | 2011 | 413 | 0.020 |
Why?
|
| Cold Temperature | 1 | 1992 | 793 | 0.020 |
Why?
|
| Bronchi | 1 | 1992 | 843 | 0.020 |
Why?
|
| Hodgkin Disease | 1 | 1996 | 1383 | 0.020 |
Why?
|
| Acute Disease | 1 | 1998 | 7236 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 1998 | 5300 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2012 | 2915 | 0.020 |
Why?
|
| Vasculitis | 1 | 1990 | 528 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2008 | 20690 | 0.020 |
Why?
|
| Medical Records | 1 | 2011 | 1408 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2011 | 2350 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2017 | 59496 | 0.010 |
Why?
|
| Health Care Surveys | 1 | 2011 | 2426 | 0.010 |
Why?
|
| Circadian Rhythm | 1 | 1995 | 2594 | 0.010 |
Why?
|
| Aged | 6 | 2017 | 171163 | 0.010 |
Why?
|
| Hospitals | 1 | 2017 | 3886 | 0.010 |
Why?
|
| Hypertension, Pulmonary | 1 | 1994 | 1604 | 0.010 |
Why?
|
| Risk Factors | 4 | 1998 | 74850 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2017 | 54807 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 1 | 1990 | 2729 | 0.010 |
Why?
|
| Time Factors | 2 | 2011 | 40097 | 0.010 |
Why?
|
| Residence Characteristics | 1 | 2011 | 2116 | 0.010 |
Why?
|
| Qualitative Research | 1 | 2012 | 3136 | 0.010 |
Why?
|
| Lung Diseases | 1 | 1990 | 1939 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 1995 | 11196 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 7423 | 0.010 |
Why?
|
| Retrospective Studies | 4 | 2011 | 81537 | 0.010 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2008 | 2027 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 1996 | 22228 | 0.010 |
Why?
|
| Arthritis, Rheumatoid | 1 | 1994 | 3743 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 1992 | 12417 | 0.010 |
Why?
|
| Hemorrhage | 1 | 1990 | 3466 | 0.010 |
Why?
|
| Physician-Patient Relations | 1 | 2011 | 3270 | 0.010 |
Why?
|
| Radiopharmaceuticals | 1 | 2008 | 2701 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2012 | 4055 | 0.010 |
Why?
|
| Length of Stay | 1 | 2011 | 6486 | 0.010 |
Why?
|
| Bronchitis | 1 | 1998 | 193 | 0.010 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 1 | 1998 | 113 | 0.010 |
Why?
|
| Curriculum | 1 | 2011 | 3784 | 0.010 |
Why?
|
| Vital Capacity | 1 | 1998 | 995 | 0.010 |
Why?
|
| Cell Transformation, Viral | 1 | 1996 | 527 | 0.010 |
Why?
|
| Young Adult | 2 | 2011 | 59857 | 0.010 |
Why?
|
| Pseudomonas | 1 | 1994 | 124 | 0.010 |
Why?
|
| Haemophilus influenzae | 1 | 1994 | 177 | 0.010 |
Why?
|
| Adolescent | 2 | 2011 | 88811 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1995 | 1527 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2018 | 65194 | 0.010 |
Why?
|
| Sulfamethoxazole | 1 | 1990 | 50 | 0.010 |
Why?
|
| Hospitalization | 1 | 2011 | 10810 | 0.010 |
Why?
|
| Trimethoprim | 1 | 1990 | 79 | 0.010 |
Why?
|
| Herpesvirus 4, Human | 1 | 1996 | 1077 | 0.010 |
Why?
|
| Haplotypes | 1 | 1996 | 2726 | 0.010 |
Why?
|
| Creatinine | 1 | 1995 | 1916 | 0.010 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 1996 | 1362 | 0.010 |
Why?
|
| DNA, Viral | 1 | 1996 | 2196 | 0.010 |
Why?
|
| Respiratory Function Tests | 1 | 1994 | 1692 | 0.010 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 1996 | 1800 | 0.000 |
Why?
|
| Tumor Cells, Cultured | 1 | 1996 | 6101 | 0.000 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1995 | 3801 | 0.000 |
Why?
|
| Staphylococcus aureus | 1 | 1994 | 1422 | 0.000 |
Why?
|
| Prednisone | 1 | 1990 | 1566 | 0.000 |
Why?
|
| Transplantation, Autologous | 1 | 1990 | 2125 | 0.000 |
Why?
|
| Lymphocyte Activation | 1 | 1996 | 5500 | 0.000 |
Why?
|
| Cyclophosphamide | 1 | 1990 | 2232 | 0.000 |
Why?
|
| Anti-Inflammatory Agents | 1 | 1994 | 1802 | 0.000 |
Why?
|
| Chronic Disease | 1 | 1998 | 9351 | 0.000 |
Why?
|
| B-Lymphocytes | 1 | 1996 | 4782 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 1996 | 18962 | 0.000 |
Why?
|
| Comorbidity | 1 | 1994 | 10575 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 1996 | 9239 | 0.000 |
Why?
|
| Phenotype | 1 | 1996 | 16714 | 0.000 |
Why?
|